Maternal antibiotic exposure increases total islet number and volume in the neonatal pancreas and reduces HbA1c and insulitis in adult female non-obese diabetic mice

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Maternal antibiotic exposure increases total islet number and volume in the neonatal pancreas and reduces HbA1c and insulitis in adult female non-obese diabetic mice. / Hansen, Camilla Hartmann Friis; Haupt-Jorgensen, Martin; Buschard, Karsten; Pakkenberg, Bente; Krych, Lukasz; Hansen, Axel Kornerup.

In: Clinical and Translational Discovery, Vol. 3, No. 2, e188, 2023.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Hansen, CHF, Haupt-Jorgensen, M, Buschard, K, Pakkenberg, B, Krych, L & Hansen, AK 2023, 'Maternal antibiotic exposure increases total islet number and volume in the neonatal pancreas and reduces HbA1c and insulitis in adult female non-obese diabetic mice', Clinical and Translational Discovery, vol. 3, no. 2, e188. https://doi.org/10.1002/ctd2.188

APA

Hansen, C. H. F., Haupt-Jorgensen, M., Buschard, K., Pakkenberg, B., Krych, L., & Hansen, A. K. (2023). Maternal antibiotic exposure increases total islet number and volume in the neonatal pancreas and reduces HbA1c and insulitis in adult female non-obese diabetic mice. Clinical and Translational Discovery, 3(2), [e188]. https://doi.org/10.1002/ctd2.188

Vancouver

Hansen CHF, Haupt-Jorgensen M, Buschard K, Pakkenberg B, Krych L, Hansen AK. Maternal antibiotic exposure increases total islet number and volume in the neonatal pancreas and reduces HbA1c and insulitis in adult female non-obese diabetic mice. Clinical and Translational Discovery. 2023;3(2). e188. https://doi.org/10.1002/ctd2.188

Author

Hansen, Camilla Hartmann Friis ; Haupt-Jorgensen, Martin ; Buschard, Karsten ; Pakkenberg, Bente ; Krych, Lukasz ; Hansen, Axel Kornerup. / Maternal antibiotic exposure increases total islet number and volume in the neonatal pancreas and reduces HbA1c and insulitis in adult female non-obese diabetic mice. In: Clinical and Translational Discovery. 2023 ; Vol. 3, No. 2.

Bibtex

@article{c488850d109a4ab5badd62660c942c0f,
title = "Maternal antibiotic exposure increases total islet number and volume in the neonatal pancreas and reduces HbA1c and insulitis in adult female non-obese diabetic mice",
abstract = "Background: Early antibiotic treatment changes susceptibility to disease in rodent models for type 1 diabetes, but the impact that gestational antibiotics may have on pancreatic embryogenesis and β cell function later in life is still unknown. Methods: Our aim was to determine whether gestational antibiotics could change islet neogenesis and function in female non-obese diabetic mouse offspring. Stereology of pancreatic islets and insulin measurements were therefore applied to 2-week-old pups from mothers either exposed or not to a broad-spectrum cocktail of ampicillin (1 g/L), vancomycin (0.5 g/L) and neomycin (1 g/L) during pregnancy. The degree of insulitis, glycated haemoglobin (HbA1c), serum cytokines and endotoxin, fasting glucose and insulin, and glucose tolerance were tested in the prediabetic pups later in life. Inflammatory and glycaemic measurements were made on the breeding females, and the gut microbiota was analysed by 16S sequencing in both the mothers and pups. Results: Antibiotics depleted the maternal microbiome and perturbed the normal gut colonisation trajectory in the pups. While Akkermansia and Rikenellaceae were later enriched in the treated pups, Bacteroides failed to colonise post-treatment. Antibiotic treatment reduced blood glucose in the mothers, weight of the pups, and HbA1c and insulitis in the adult offspring and increased anti-inflammatory CD4+ natural killer T cells. This was preceded by more than 50% increase in total islet number and volume, and increased insulin levels in postnatal life. No changes were observed in their homeostatic model assessment of insulin resistance (HOMA-IR) and β cell function (HOMA-β), serum endotoxin or cytokine levels later in life, but the glucose tolerance response was altered in the treated offspring, which suggested an improvement in β cell exhaustion that may have left the islets less vulnerable to destruction. Conclusion: Our study highlights the importance of considering maternal microbiota-modulating factors as determinants that may mitigate or aggravate diabetes via changes in islet maturation and β cell function in perinatal life.",
keywords = "Akkermansia, antibiotics, gestation, gut microbiota, non-obese diabetic mice, pancreatic islet neogenesis, stereology, type 1 diabetes",
author = "Hansen, {Camilla Hartmann Friis} and Martin Haupt-Jorgensen and Karsten Buschard and Bente Pakkenberg and Lukasz Krych and Hansen, {Axel Kornerup}",
note = "Publisher Copyright: {\textcopyright} 2023 The Authors. Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.",
year = "2023",
doi = "10.1002/ctd2.188",
language = "English",
volume = "3",
journal = "Clinical and Translational Discovery",
issn = "2768-0622",
publisher = "Wiley Open Access",
number = "2",

}

RIS

TY - JOUR

T1 - Maternal antibiotic exposure increases total islet number and volume in the neonatal pancreas and reduces HbA1c and insulitis in adult female non-obese diabetic mice

AU - Hansen, Camilla Hartmann Friis

AU - Haupt-Jorgensen, Martin

AU - Buschard, Karsten

AU - Pakkenberg, Bente

AU - Krych, Lukasz

AU - Hansen, Axel Kornerup

N1 - Publisher Copyright: © 2023 The Authors. Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

PY - 2023

Y1 - 2023

N2 - Background: Early antibiotic treatment changes susceptibility to disease in rodent models for type 1 diabetes, but the impact that gestational antibiotics may have on pancreatic embryogenesis and β cell function later in life is still unknown. Methods: Our aim was to determine whether gestational antibiotics could change islet neogenesis and function in female non-obese diabetic mouse offspring. Stereology of pancreatic islets and insulin measurements were therefore applied to 2-week-old pups from mothers either exposed or not to a broad-spectrum cocktail of ampicillin (1 g/L), vancomycin (0.5 g/L) and neomycin (1 g/L) during pregnancy. The degree of insulitis, glycated haemoglobin (HbA1c), serum cytokines and endotoxin, fasting glucose and insulin, and glucose tolerance were tested in the prediabetic pups later in life. Inflammatory and glycaemic measurements were made on the breeding females, and the gut microbiota was analysed by 16S sequencing in both the mothers and pups. Results: Antibiotics depleted the maternal microbiome and perturbed the normal gut colonisation trajectory in the pups. While Akkermansia and Rikenellaceae were later enriched in the treated pups, Bacteroides failed to colonise post-treatment. Antibiotic treatment reduced blood glucose in the mothers, weight of the pups, and HbA1c and insulitis in the adult offspring and increased anti-inflammatory CD4+ natural killer T cells. This was preceded by more than 50% increase in total islet number and volume, and increased insulin levels in postnatal life. No changes were observed in their homeostatic model assessment of insulin resistance (HOMA-IR) and β cell function (HOMA-β), serum endotoxin or cytokine levels later in life, but the glucose tolerance response was altered in the treated offspring, which suggested an improvement in β cell exhaustion that may have left the islets less vulnerable to destruction. Conclusion: Our study highlights the importance of considering maternal microbiota-modulating factors as determinants that may mitigate or aggravate diabetes via changes in islet maturation and β cell function in perinatal life.

AB - Background: Early antibiotic treatment changes susceptibility to disease in rodent models for type 1 diabetes, but the impact that gestational antibiotics may have on pancreatic embryogenesis and β cell function later in life is still unknown. Methods: Our aim was to determine whether gestational antibiotics could change islet neogenesis and function in female non-obese diabetic mouse offspring. Stereology of pancreatic islets and insulin measurements were therefore applied to 2-week-old pups from mothers either exposed or not to a broad-spectrum cocktail of ampicillin (1 g/L), vancomycin (0.5 g/L) and neomycin (1 g/L) during pregnancy. The degree of insulitis, glycated haemoglobin (HbA1c), serum cytokines and endotoxin, fasting glucose and insulin, and glucose tolerance were tested in the prediabetic pups later in life. Inflammatory and glycaemic measurements were made on the breeding females, and the gut microbiota was analysed by 16S sequencing in both the mothers and pups. Results: Antibiotics depleted the maternal microbiome and perturbed the normal gut colonisation trajectory in the pups. While Akkermansia and Rikenellaceae were later enriched in the treated pups, Bacteroides failed to colonise post-treatment. Antibiotic treatment reduced blood glucose in the mothers, weight of the pups, and HbA1c and insulitis in the adult offspring and increased anti-inflammatory CD4+ natural killer T cells. This was preceded by more than 50% increase in total islet number and volume, and increased insulin levels in postnatal life. No changes were observed in their homeostatic model assessment of insulin resistance (HOMA-IR) and β cell function (HOMA-β), serum endotoxin or cytokine levels later in life, but the glucose tolerance response was altered in the treated offspring, which suggested an improvement in β cell exhaustion that may have left the islets less vulnerable to destruction. Conclusion: Our study highlights the importance of considering maternal microbiota-modulating factors as determinants that may mitigate or aggravate diabetes via changes in islet maturation and β cell function in perinatal life.

KW - Akkermansia

KW - antibiotics

KW - gestation

KW - gut microbiota

KW - non-obese diabetic mice

KW - pancreatic islet neogenesis

KW - stereology

KW - type 1 diabetes

U2 - 10.1002/ctd2.188

DO - 10.1002/ctd2.188

M3 - Journal article

AN - SCOPUS:85161633091

VL - 3

JO - Clinical and Translational Discovery

JF - Clinical and Translational Discovery

SN - 2768-0622

IS - 2

M1 - e188

ER -

ID: 363057876